Industry litigation – Page 14
-
BusinessExxonMobil sued for Clean Air Act violations
Environmental campaigners claim ExxonMobil’s plant emissions harm local residents
-
BusinessDow to settle polyurethane price-fixing case
Chemical giant cancels Supreme Court appeal of damages and agrees $835m settlement
-
Business
EPA aims to remove flubendiamide pesticide from market
After reassessing environmental impact, the agency wants to withdraw Bayer and Nichino America insecticides
-
Business
Illumina to sue Oxford Nanopore over patent infringement
UK firm’s use of pore proteins in DNA sequencing alleged to contravene two Illumina patents
-
Business
Glyphosate persistence raises questions
Herbicide remains in water and soil longer than thought, but how that translates to human and environmental risk is unclear
-
Business
Pfizer agrees potential $785m fraud settlement
Whistleblower case relates to claims of Wyeth overcharging for acid reflux drugs between 2001 and 2006
-
Business
Lilly loses UK patent challenge
Allergan’s cancer drug generics do not infringe patents, say UK courts
-
Business
GSK fined for stalling antidepressant generics
UK Competition and Markets Authority deems pay-for-delay deal illegal and imposes £45m in fines
-
Business
Seed secrets thief jailed
Chinese born US citizen pleads guilty to conspiring to steal trade secrets from DuPont Pioneer and Monsanto
-
BusinessGSK scientists indicted for trade secret theft
Two researchers accused of passing research data and manufacturing details to Chinese firm
-
BusinessClinical trial death highlights hazards
Pain drug trial has left one dead and five hospitalised in France, with little indication as to the cause of the problems
-
Business
Monsanto adds 1000 to job cut tally
Cost reduction plan brings cuts up to 16% of global workforce by the end of 2018
-
-
Business
EPA acts to halt approval of Dow’s Enlist Duo herbicide
US environmental agency wants registration of controversial herbicide halted, pending review of new toxicity data
-
BusinessViral cancer therapy approved in the US
T-Vec is the first approved oncolytic virus, but its limited treatment scope means it is unlikely to become a blockbuster
-
BusinessPharma kickback claims lead to individual prosecutions
Warner Chilcott and Novartis face large fines for paying doctors to prescribe their drugs
-
Business
Nine dead in China plant blast
Explosion in Shandong province latest of several incidents in Chinese chemical plants
-
BusinessDuPont found liable for cancer case
US court orders firm to pay $1.6m in damages for disease linked to contaminated water supply
-
Business
EPA fines Mosaic Fertilizer over hazardous waste handling
US Environmental Protection Agency agrees settlement contract including $8m penalty and $800m in investments
-
BusinessControversial new trade deal finalised
The Trans-Pacific Partnership could raise the price of medicines, especially in developing nations